Is there an increased risk of severe COVID-19 among patients with systemic lupus erythematosus treated with anifrolumab?
Origin | Files produced by the author(s) |
---|
_ |
Origin | Files produced by the author(s) |
---|
Paul Breillat : Connect in order to contact the contributor
https://hal.sorbonne-universite.fr/hal-04080166
Submitted on : Monday, July 3, 2023-10:02:35 AM
Last modification on : Friday, April 19, 2024-1:20:30 PM